Al Price, PhD

Senior Director, IAVI

International AIDS Vaccine Initiative 125 Broad Street, 9th Floor New York, NY 10004

Albert Price is Senior Director, CMC Development at IAVI, where he leads efforts to rapidly advance the most promising vaccine efforts from research laboratories into clinical trials and harness new technologies to accelerate the product development process.


Albert Price has over 20 years of industry R&D experience with small and large biopharma companies, focusing on discovery, process development and GMP manufacturing of novel vaccine candidates. His prior experience includes work on vaccine candidates for HIV/AIDS, influenza, Respiratory Syncytial Virus, S. aureus, Dengue, malaria and cancer.

Training and Education

  • 2004
    Postdoctoral Fellow, Molecular Cell Biology, Yale University School of Medicine
  • 1999
    PhD, Biochemistry, Geisel School of Medicine at Dartmouth
  • 1989
    BS, Biology, Bates College